Impact of Cancer Research Bureaucracy on Innovation, Costs, and Patient Care
Author:
Affiliation:
1. Dana-Farber Cancer Institute-Harvard Medical School, Boston, MA
2. The University of Texas MD Anderson Cancer Center, Houston, TX
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Reference24 articles.
1. Phase III Clinical Trial Development: A Process of Chutes and Ladders
2. The Ordinary Miracle of Cancer Clinical Trials
3. Global clinical trials are burdened by excessive bureaucracy, conference hears
4. Clinical trials bureaucracy: unintended consequences of well-intentioned policy
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Dynamic Network Model of Societal Complexity and Resilience Inspired by Tainter’s Theory of Collapse;Entropy;2024-01-23
2. Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forward;Neuro-Oncology Advances;2024-01-01
3. Drugdevelopr: Planning of Phase Ii/Iii Drug Development Programs with Optimal Sample Size Allocation and Go/No-Go Decision Rules in R;2024
4. Unlocking digitally enabled research in oncology: the time is now;ESMO Open;2023-10
5. The safety risk of information overload and bureaucracy in oncology clinical trial conduct;European Journal of Cancer;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3